20503 ⎘
Medicinal preparations containing organic active ingredients; Phosphorus compounds having sulfur as a ring hetero atom
STAT6 DEGRADERS AND USES THEREOF
#2STING AGONIST COMPOUNDS
#3PHOSPHORUS COMPOUND AND USE THEREOF
#4MITOCHONDRIOTROPIC HETEROARYL BENZAMIDE POTASSIUM CHANNEL KV1.3 INHIBITORS
#5Therapeutic use of hydrogen sulfide in frostbite injury
#6SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF
#7COMPOUNDS TARGETING MUTANT OF P53
#8ASYMMETRIC GPR84 ANTAGONIST AND USE THEREOF
#9Method of treating a methionine-dependent cancer
#10ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#11METHOD FOR TREATING CANCER WITH A COMBINATION OF QUERCETIN AND A CHEMOTHERAPY AGENT
#12AP39 IMPACT ON MITOCHONDRIA, METABOLISM, GENE TRANSCRIPTION REGULATION, CARDIOTOXICITY PROTECTION AND CANCER TREATMENT
#13Method and compositions for protecting tissue
#14Method of treating a methionine-dependent cancer
#15METHOD FOR TREATING CANCER WITH A COMBINATION OF QUERCETIN AND A CHEMOTHERAPY AGENT
#16Phosphinic peptide derivatives for use as MMP-12 inhibitors
#17TC-PTP inhibitors as APC activators for immunotherapy
#18Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy
#19TC-PTP inhibitors as APC activators for immunotherapy
#20Pharmaceutical Composition Consisting of Ceftaroline Fosamil Acetic Acid Solvate Particles Arginine Particles, Both Having A Specific Particle Size Distribution
#21Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy
#22TC-PTP inhibitors as APC activators for immunotherapy
#23Dithiol compounds, derivatives, and uses therefor
#24Predictive biomarker for hypoxia-activated prodrug therapy
#25METHOD FOR TREATING CANCER WITH A COMBINATION OF QUERCETIN AND A CHEMOTHERAPY AGENT
#26Methods of treating ocular diseases using derivatives of lipoic acid
#27Cytotoxic-drug delivering molecules targeting HIV (CDM-Hs), cytotoxic activity against the human immunodeficiency virus and methods of use
#28Methods of treating ocular diseases using derivatives of lipoic acid
#29Aminophosphinic derivatives that can be used in the treatment of pain
#30Inhibitors of flaviviridae viruses
#31METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES USING IMMUNOMODULATORY AGENTS
#32Inhibitors of viruses
#33Aminophosphinic derivatives that can be used in the treatment of pain
#34Methods of treating a family viral infection and compositions for treating a family viral infection
#35Methods of treating ocular diseases using derivatives of lipoic acid
#36Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
#37PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II
#38Antimicrobial Composition
#39Composition Comprising a NSAID and Paracetamol
#40POLYMER-LINKED-BIOPHOSPHONATE INHALANT FORMULATIONS AND METHODS FOR USING THE SAME
#41Aerosol Formulation Comprising Formoterol in Suspension
#42Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators
#43Signals and molecular species involved in senescence
#44Cancer treatment including glycolytic inhibitors
#45Cancer treatment including glycolytic inhibitors